4D Molecular Therapeutics Inc (NAS:FDMT)
$ 10.77 +0.18 (+1.7%) Market Cap: 562.75 Mil Enterprise Value: 192.40 Mil PE Ratio: 0 PB Ratio: 1.25 GF Score: 59/100

4D Molecular Therapeutics Inc at RBC Capital Markets Global Healthcare Conference Transcript

May 19, 2026 / 06:35 PM GMT
Release Date Price: $8.41 (+0.48%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

FDMT.OQ - 4D Molecular Therapeutics Inc
4D Molecular Therapeutics Inc at RBC Capital Markets Global Healthcare Conference
May 19, 2026 / 06:35PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Lisa Walter, Biotech Analyst here at RBC Capital Markets. Thanks for joining us at RBC's 2026 Global Healthcare Conference. This session, we have 4D Molecular Therapeutics, and we have the pleasure of hosting Chris Sims, who's the Chief Commercial and Business Officer, and Christian Hummer, who is the Chief Financial Officer. Chris, Christian, thanks so much for joining us today. How are you both doing?

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
We're great. It's great to be here. Thanks for the opportunity.

------------
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot